FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3042362821> ?p ?o ?g. }

• W3042362821 endingPage "1502" @default.
• W3042362821 startingPage "1495" @default.
• W3042362821 abstract "Peri-procedural i.v. fluid administration is important for the prevention of contrast-induced acute kidney injury (CI-AKI). However, standardized fluid management protocols may not be suitable for all patients. We therefore wished to determine whether an individualized fluid administration protocol guided by measuring extracellular water (ECW) using bioimpedance analysis (BIA) would be safe and would reduce the incidence CI-AKI compared to a standardized fluid administration prescription.In this pilot, randomized, parallel-group, single-blind, controlled trial, we compared the effect of BIA-guided isotonic bicarbonate administration according to the ratio of ECW to total body water (ECW/TBW) to our standard isotonic bicarbonate protocol in regard to the safety and efficacy of preventing CI-AKI in chronic kidney disease patients undergoing elective cardiac angiography. Our primary outcome was the incidence of CI-AKI, which was defined as a ≥0.3 mg/dl or 150% increase in serum creatinine concentration within 48 to 72 hours after cardiac angiography.We studied 61 patients, 30 in the bioimpedance group and 31 in the control group. Age was similar (72.5 ± 7 vs. 71.4 ± 7.9 years), as were body mass index (25.5 vs. 25.8 kg/m2) and baseline serum creatinine (1.3 ± 0.3 vs. 1.4 ± 0.4 mg/dl). The peri-procedural fluid volume administered was significantly greater in the BIA-guided hydration group (899.0 ± 252.7 ml vs. 594.4 ± 125.9 ml, P < .01). The incidence of CI-AKI was 3.3% in BIA-guided hydration group and 6.5% in the control group (relative risk = 0.52, 95% confidence interval = 0.05-5.40, P = 1.00). Adverse events reported were comparable between groups (6.7% vs. 6.5%, P = 1.00).The overall incidence of CI-AKI after cardiac angiography in our patients with mild-to-moderate renal insufficiency was lower than anticipated. Isotonic bicarbonate administration guided by bioimpedance measurements was safe, and probably led to a lower incidence of CI-AKI, although this not reach statistical significance." @default.
• W3042362821 created "2020-07-23" @default.
• W3042362821 creator A5037889417 @default.
• W3042362821 creator A5053763802 @default.
• W3042362821 creator A5056527532 @default.
• W3042362821 creator A5063273525 @default.
• W3042362821 creator A5064423428 @default.
• W3042362821 creator A5075305936 @default.
• W3042362821 creator A5084766453 @default.
• W3042362821 creator A5086999009 @default.
• W3042362821 creator A5088913338 @default.
• W3042362821 date "2020-09-01" @default.
• W3042362821 modified "2023-10-16" @default.
• W3042362821 title "Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)" @default.
• W3042362821 cites W115559861 @default.
• W3042362821 cites W1970052157 @default.
• W3042362821 cites W1993595275 @default.
• W3042362821 cites W2011689015 @default.
• W3042362821 cites W2046597089 @default.
• W3042362821 cites W2050044991 @default.
• W3042362821 cites W2056753991 @default.
• W3042362821 cites W2065661664 @default.
• W3042362821 cites W2097637956 @default.
• W3042362821 cites W2106716422 @default.
• W3042362821 cites W2108160133 @default.
• W3042362821 cites W2128700599 @default.
• W3042362821 cites W2128803585 @default.
• W3042362821 cites W2131058030 @default.
• W3042362821 cites W2138012664 @default.
• W3042362821 cites W2149758519 @default.
• W3042362821 cites W2153104532 @default.
• W3042362821 cites W2157672682 @default.
• W3042362821 cites W2191946097 @default.
• W3042362821 cites W2316461329 @default.
• W3042362821 cites W2786550682 @default.
• W3042362821 cites W2808165335 @default.
• W3042362821 cites W2900850987 @default.
• W3042362821 cites W2970103288 @default.
• W3042362821 cites W4211164073 @default.
• W3042362821 doi "https://doi.org/10.1016/j.ekir.2020.07.009" @default.
• W3042362821 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7486189" @default.
• W3042362821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32954073" @default.
• W3042362821 hasPublicationYear "2020" @default.
• W3042362821 type Work @default.
• W3042362821 sameAs 3042362821 @default.
• W3042362821 citedByCount "1" @default.
• W3042362821 countsByYear W30423628212022 @default.
• W3042362821 crossrefType "journal-article" @default.
• W3042362821 hasAuthorship W3042362821A5037889417 @default.
• W3042362821 hasAuthorship W3042362821A5053763802 @default.
• W3042362821 hasAuthorship W3042362821A5056527532 @default.
• W3042362821 hasAuthorship W3042362821A5063273525 @default.
• W3042362821 hasAuthorship W3042362821A5064423428 @default.
• W3042362821 hasAuthorship W3042362821A5075305936 @default.
• W3042362821 hasAuthorship W3042362821A5084766453 @default.
• W3042362821 hasAuthorship W3042362821A5086999009 @default.
• W3042362821 hasAuthorship W3042362821A5088913338 @default.
• W3042362821 hasBestOaLocation W30423628211 @default.
• W3042362821 hasConcept C120665830 @default.
• W3042362821 hasConcept C121332964 @default.
• W3042362821 hasConcept C126322002 @default.
• W3042362821 hasConcept C126894567 @default.
• W3042362821 hasConcept C147583825 @default.
• W3042362821 hasConcept C159641895 @default.
• W3042362821 hasConcept C168563851 @default.
• W3042362821 hasConcept C2113261 @default.
• W3042362821 hasConcept C2778653478 @default.
• W3042362821 hasConcept C2780306776 @default.
• W3042362821 hasConcept C2780472472 @default.
• W3042362821 hasConcept C28406088 @default.
• W3042362821 hasConcept C42219234 @default.
• W3042362821 hasConcept C61511704 @default.
• W3042362821 hasConcept C71924100 @default.
• W3042362821 hasConcept C84029825 @default.
• W3042362821 hasConcept C86803240 @default.
• W3042362821 hasConcept C95444343 @default.
• W3042362821 hasConceptScore W3042362821C120665830 @default.
• W3042362821 hasConceptScore W3042362821C121332964 @default.
• W3042362821 hasConceptScore W3042362821C126322002 @default.
• W3042362821 hasConceptScore W3042362821C126894567 @default.
• W3042362821 hasConceptScore W3042362821C147583825 @default.
• W3042362821 hasConceptScore W3042362821C159641895 @default.
• W3042362821 hasConceptScore W3042362821C168563851 @default.
• W3042362821 hasConceptScore W3042362821C2113261 @default.
• W3042362821 hasConceptScore W3042362821C2778653478 @default.
• W3042362821 hasConceptScore W3042362821C2780306776 @default.
• W3042362821 hasConceptScore W3042362821C2780472472 @default.
• W3042362821 hasConceptScore W3042362821C28406088 @default.
• W3042362821 hasConceptScore W3042362821C42219234 @default.
• W3042362821 hasConceptScore W3042362821C61511704 @default.
• W3042362821 hasConceptScore W3042362821C71924100 @default.
• W3042362821 hasConceptScore W3042362821C84029825 @default.
• W3042362821 hasConceptScore W3042362821C86803240 @default.
• W3042362821 hasConceptScore W3042362821C95444343 @default.
• W3042362821 hasFunder F4320322401 @default.
• W3042362821 hasFunder F4320326657 @default.
• W3042362821 hasIssue "9" @default.
• W3042362821 hasLocation W30423628211 @default.

• next